Tearsheet

Bio-Rad Laboratories (BIO-B)

Market Price (9/4/2025): $286.9 | Market Cap: $7.8 Bil
Sector: Health Care | Industry: Life Sciences Tools & Services

Bio-Rad Laboratories (BIO-B)

Market Price (9/4/2025): $286.9
Market Cap: $7.8 Bil
Sector: Health Care
Industry: Life Sciences Tools & Services

Market Valuation

	9/4/25	2024	2023	2022	2021
Share Price CYE	$286.90	$325.60	$320.65	$404.66	$722.91
Market Cap CYE ($ Bil)	7.8	9.1	9.2	12.0	21.6
Total Debt ($ Bil)	1.4	1.4	1.4	1.4	0.2
Total Cash ($ Bil)	1.4	1.7	1.6	1.8	0.9
Enterprise Value ($ Bil)	7.8	10.5	10.6	13.4	21.8
Valuation Ratios
P/S TTM	3.1	3.6	3.5	4.3	7.4
P/EBIT TTM	15.7	-4.0	-11.7	-2.6	4.0
P/E TTM	24.5	-5.0	-14.7	-3.3	5.1
Sector Ratios
P/S TTM (Sector)	3.8	4.1	4.5	4.5	6.7
P/EBIT TTM (Sector)	4.3	0.4	-1.9	-1.2	-0.4
P/E TTM (Sector)	-1.8	-2.2	-3.4	-2.2	-2.3

	9/4/25	2024	2023
Share Price CYE	$286.90	$325.60	$320.65
Market Cap CYE ($ Bil)	7.8	9.1	9.2
Total Debt ($ Bil)	1.4	1.4	1.4
Total Cash ($ Bil)	1.4	1.7	1.6
Enterprise Value ($ Bil)	7.8	10.5	10.6
Valuation Ratios
P/S TTM	3.1	3.6	3.5
P/EBIT TTM	15.7	-4.0	-11.7
P/E TTM	24.5	-5.0	-14.7
Sector Ratios
P/S TTM (Sector)	3.8	4.1	4.5
P/EBIT TTM (Sector)	4.3	0.4	-1.9
P/E TTM (Sector)	-1.8	-2.2	-3.4

Stock Price
Market Cap

Stock Price Chart

Return (1Y):

Market Cap Chart

Business Description

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. Show more

Price Returns Compared

Expand for Detailed View

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
BIO-B Return	55%	26%	-44%	-21%	2%	-25%	-37%
Peers Return	143%	-18%	-38%	3%	-36%	17%	-4%
S&P 500 Return	16%	27%	-19%	24%	23%	10%	100%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: A, ATEC, CERS, BIIO, DGWPF.
[3] 2025 data is for the year up to 9/3/2025 (YTD)

Latest Trefis Analyses

	Title	Topic
0	DASHBOARDS
1	Bio-Rad Laboratories Total Shareholder Return (TSR): 1.5% in 2024 and 0% 3-yr returns (below peer average)

	Title
0	ARTICLES
1	Bio-Rad Laboratories Total Shareholder Return (TSR): 1.5% in 2024 and 0% 3-yr returns (below peer average)

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	XELA	Exela Technologies	212.4%	-95.5%
2	TKCM	Token Communities	82.8%	-64.7%
3	ANGGF	Angang Steel	61.2%	25.0%
4	BATMF	British American Tobacco Malaysia	43.4%	59.2%
5	KYSEF	Kyushu Electric Power	32.1%	32.1%
6	STTK	Shattuck Labs	26.7%	5.8%
7	KTHAF	Krung Thai Bank	24.0%	24.0%
8	SFOSF	Shanghai Fosun Pharmaceutical	23.7%	61.7%
9	INDOY	Indorama Ventures	20.9%	-5.5%
10	M	Macy's	20.7%	-1.0%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	PTLKF	PT Lippo Karawaci	-95.2%	-94.7%
2	MGAWF	Megaworld	-71.0%	-71.0%
3	PTTMF	PT Timah	-62.8%	-83.1%
4	PTJSF	PT Jasa Marga	-50.9%	-50.9%
5	UNLRF	PT Unilever Indonesia	-41.3%	-17.6%
6	DLNDY	D&L Industries	-37.5%	-30.7%
7	SUCEF	Sumitomo Osaka Cement	-37.4%	-37.4%
8	PTKFF	PT Kalbe Farma	-34.7%	-32.1%
9	SMTGF	SMA Solar Technology	-30.1%	28.4%
10	PMDKF	PT Mitra Adiperkasa	-28.6%	-48.9%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	EAF	GrafTech International	804.0%	-47.2%
2	RLMD	Relmada Therapeutics	122.3%	182.7%
3	XELA	Exela Technologies	109.6%	-95.5%
4	PSNYW	Polestar Automotive UK	96.2%	141.5%
5	TKCM	Token Communities	82.8%	-64.7%
6	PHJMF	PT Hanjaya Mandala Sampoerna	66.7%	34.8%
7	ANGGF	Angang Steel	61.2%	25.0%
8	DTNOF	DNO	49.5%	141.9%
9	BW	Babcock & Wilcox Enterprises	48.5%	54.9%
10	MDB	MongoDB	46.0%	34.4%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	COSG	Grand Gallery	-100.0%	�
2	PTLKF	PT Lippo Karawaci	-95.2%	-94.7%
3	NXTT	Next Technology	-74.5%	-89.4%
4	SCGY	Scientific Energy	-72.7%	-26.9%
5	MGAWF	Megaworld	-71.0%	-71.0%
6	TTOO	T2 Biosystems	-67.7%	-99.0%
7	PTTMF	PT Timah	-62.8%	-83.1%
8	PIGEF	Pigeon	-62.4%	-62.4%
9	NEGG	Newegg Commerce	-53.8%	290.6%
10	PTJSF	PT Jasa Marga	-50.9%	-50.9%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	MMEX	MMEX Resources	∞%	-50.0%
2	TAWNF	Thai Airways International	3674.5%	3400.0%
3	NOKPF	Nok Airlines	2400.0%	81.8%
4	AYRWF	Ayr Wellness	509.5%	-94.6%
5	XELA	Exela Technologies	379.0%	-95.5%
6	SRNE	Sorrento Therapeutics	233.3%	900.0%
7	PGEN	Precigen	169.9%	324.1%
8	TLS	Telos	154.7%	89.2%
9	SATS	EchoStar	142.7%	179.1%
10	RLMD	Relmada Therapeutics	139.0%	182.7%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	COSG	Grand Gallery	-100.0%	�
2	PTLKF	PT Lippo Karawaci	-95.2%	-94.7%
3	TTOO	T2 Biosystems	-94.8%	-99.0%
4	NXTT	Next Technology	-86.5%	-89.4%
5	OTRK	Ontrak	-78.2%	-96.6%
6	SCGY	Scientific Energy	-72.7%	-26.9%
7	PPCB	Propanc Biopharma	-72.1%	-79.1%
8	MGAWF	Megaworld	-71.0%	-71.0%
9	PTTMF	PT Timah	-62.8%	-83.1%
10	PIGEF	Pigeon	-62.4%	-62.4%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	XELA	Exela Technologies	212.4%	-95.5%
2	TKCM	Token Communities	82.8%	-64.7%
3	ANGGF	Angang Steel	61.2%	25.0%
4	BATMF	British American Tobacco Malaysia	43.4%	59.2%
5	KYSEF	Kyushu Electric Power	32.1%	32.1%
6	STTK	Shattuck Labs	26.7%	5.8%
7	KTHAF	Krung Thai Bank	24.0%	24.0%
8	SFOSF	Shanghai Fosun Pharmaceutical	23.7%	61.7%
9	INDOY	Indorama Ventures	20.9%	-5.5%
10	M	Macy's	20.7%	-1.0%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	PTLKF	PT Lippo Karawaci	-95.2%	-94.7%
2	MGAWF	Megaworld	-71.0%	-71.0%
3	PTTMF	PT Timah	-62.8%	-83.1%
4	PTJSF	PT Jasa Marga	-50.9%	-50.9%
5	UNLRF	PT Unilever Indonesia	-41.3%	-17.6%
6	DLNDY	D&L Industries	-37.5%	-30.7%
7	SUCEF	Sumitomo Osaka Cement	-37.4%	-37.4%
8	PTKFF	PT Kalbe Farma	-34.7%	-32.1%
9	SMTGF	SMA Solar Technology	-30.1%	28.4%
10	PMDKF	PT Mitra Adiperkasa	-28.6%	-48.9%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	EAF	GrafTech International	804.0%	-47.2%
2	RLMD	Relmada Therapeutics	122.3%	182.7%
3	XELA	Exela Technologies	109.6%	-95.5%
4	PSNYW	Polestar Automotive UK	96.2%	141.5%
5	TKCM	Token Communities	82.8%	-64.7%
6	PHJMF	PT Hanjaya Mandala Sampoerna	66.7%	34.8%
7	ANGGF	Angang Steel	61.2%	25.0%
8	DTNOF	DNO	49.5%	141.9%
9	BW	Babcock & Wilcox Enterprises	48.5%	54.9%
10	MDB	MongoDB	46.0%	34.4%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	COSG	Grand Gallery	-100.0%	�
2	PTLKF	PT Lippo Karawaci	-95.2%	-94.7%
3	NXTT	Next Technology	-74.5%	-89.4%
4	SCGY	Scientific Energy	-72.7%	-26.9%
5	MGAWF	Megaworld	-71.0%	-71.0%
6	TTOO	T2 Biosystems	-67.7%	-99.0%
7	PTTMF	PT Timah	-62.8%	-83.1%
8	PIGEF	Pigeon	-62.4%	-62.4%
9	NEGG	Newegg Commerce	-53.8%	290.6%
10	PTJSF	PT Jasa Marga	-50.9%	-50.9%

Peer Comparisons for Bio-Rad Laboratories

Financials

	BIO-B	A	ATEC	CERS	BIIO	DGWPF	Median
Name	Bio-Rad .	Agilent .	Alphatec	Cerus	Bionovat.	Draegerw.
Mkt Price	-	125.22	15.90	1.31	-	-	15.90
Mkt Cap	-	35.6	2.4	0.3	-	-	2.4
Rev LTM	-	6,788	682	193	0	3,361	682
Op Inc LTM	-	1,444	-95	-12	-0	144	-0
FCF LTM	-	1,088	-32	3	0	122	3
FCF 3Y Avg	-	1,308	-123	-16	0	80	0
CFO LTM	-	1,495	16	6	0	191	16
CFO 3Y Avg	-	1,662	-45	-13	0	148	0

Growth & Margins

	BIO-B	A	ATEC	CERS	BIIO	DGWPF	Median
Name	Bio-Rad .	Agilent .	Alphatec	Cerus	Bionovat.	Draegerw.
Rev Chg LTM	-	4.5%	26.3%	13.3%	-	-0.0%	8.9%
Rev Chg 3Y Avg	-	0.8%	33.0%	7.8%	-	4.0%	5.9%
Rev Chg Q	-	10.1%	27.5%	16.3%	-	-0.6%	13.2%
QoQ Delta Rev Chg LTM	-	2.4%	6.2%	4.0%	-	-0.1%	3.2%
Op Mgn LTM	-	21.3%	-13.9%	-6.1%	-	4.3%	-0.9%
Op Mgn 3Y Avg	-	21.5%	-24.2%	-13.8%	-	4.1%	-4.8%
QoQ Delta Op Mgn LTM	-	-0.1%	4.2%	0.5%	-	-0.6%	0.2%
CFO/Rev LTM	-	22.0%	2.3%	3.0%	-	5.7%	4.3%
CFO/Rev 3Y Avg	-	24.6%	-9.6%	-8.2%	-	4.4%	-1.9%
FCF/Rev LTM	-	16.0%	-4.6%	1.8%	-	3.6%	2.7%
FCF/Rev 3Y Avg	-	19.4%	-24.6%	-10.2%	-	2.4%	-3.9%

Valuation

	BIO-B	A	ATEC	CERS	BIIO	DGWPF	Median
Name	Bio-Rad .	Agilent .	Alphatec	Cerus	Bionovat.	Draegerw.
Mkt Cap	-	35.6	2.4	0.3	-	-	2.4
P/S	-	5.2	3.5	1.3	-	-	3.5
P/EBIT	-	23.5	-18.1	-25.0	-	-	-18.1
P/E	-	29.1	-14.4	-13.3	-	-	-13.3
P/CFO	-	23.8	151.9	43.9	-	-	43.9
Total Yield	-	4.2%	-7.0%	-7.5%	-	-	-7.0%
Dividend Yield	-	0.8%	0.0%	0.0%	-	-	0.0%
FCF Yield 3Y Avg	-	3.7%	-7.3%	-4.2%	-	-	-4.2%
D/E	-	0.1	0.2	0.4	-	-	0.2
Net D/E	-	0.1	0.2	0.1	-	-	0.1

Returns

	BIO-B	A	ATEC	CERS	BIIO	DGWPF	Median
Name	Bio-Rad .	Agilent .	Alphatec	Cerus	Bionovat.	Draegerw.
1M Rtn	-	9.0%	6.9%	0.8%	-	-	6.9%
3M Rtn	-	9.2%	29.5%	-9.0%	-	-	9.2%
6M Rtn	-	-0.6%	39.0%	-18.6%	-	-	-0.6%
12M Rtn	-	-9.2%	133.8%	-40.2%	-	-	-9.2%
3Y Rtn	-	-0.0%	117.5%	-66.6%	-	-	-0.0%
1M Excs Rtn	-	7.2%	5.1%	-1.1%	-	-	5.1%
3M Excs Rtn	-	3.3%	17.6%	-17.0%	-	-	3.3%
6M Excs Rtn	-	-9.4%	24.0%	-28.7%	-	-	-9.4%
12M Excs Rtn	-	-26.8%	116.8%	-58.1%	-	-	-26.8%
3Y Excs Rtn	-	-60.4%	44.1%	-128.5%	-	-	-60.4%

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End		12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date		2/14/2025	2/16/2024	2/17/2023	2/11/2022	2/16/2021	3/2/2020
Key Financials
Total Revenue	2,554	2,566	2,671	2,802	2,923	2,546	2,312
Ebitda	656	-2,142	-655	-4,529	5,588	5,078	2,419
Operating Income	224	269	338	475	500	421	230
Net Income	319	-1,844	-637	-3,628	4,254	3,814	1,759
EPS	11.76	-65.36	-21.82	-121.79	142.61	128.13	58.93
Growth Rates
Total Revenue Growth	-0.3%	-3.9%	-4.7%	-4.1%	14.8%	10.1%	1.0%
EBITDA Growth	142.8%	-227.1%	85.5%	-181.0%	10.0%	110.0%	258.5%
Operating Income Growth	-32.7%	-20.4%	-28.9%	-5.0%	18.8%	83.5%	21.4%
Net Income Growth	124.1%	-189.4%	82.4%	-185.3%	11.5%	116.9%	381.0%
Margins
EBITDA Margin	25.7%	-83.5%	-24.5%	-161.6%	191.2%	199.5%	104.6%
Operating Income Margin	8.8%	10.5%	12.6%	17.0%	17.1%	16.6%	9.9%
Net Income Margin	12.5%	-71.9%	-23.9%	-129.5%	145.6%	149.8%	76.1%
Cash & Debt
Total Cash	1,374	1,664	1,607	1,791	870	991	1,115
Total Debt	1,406	1,375	1,406	1,388	223	226	651
Net Debt / (Cash)	33	-290	-202	-403	-647	-765	-463
Cash Flows
Net Cash from Operations	534	455	375	194	669	585	458
Free Cash from Operations	348	266	218	80	536	476	359
Returns to Shareholders
Dividends	0	-0	-0	-0	-0	-0	-0
Share Repurchases	340	204	429	216	50	100	28

$ Mil \| FY: 12/31	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3
Period End	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Filing Date	7/31/2025	5/1/2025	2/14/2025	10/31/2024	8/2/2024	5/8/2024	2/16/2024	10/27/2023	8/4/2023	5/5/2023	2/17/2023	10/28/2022
Key Financials Quarterly
Total Revenue	652	585	667	650	638	611	681	632	681	677	730	681
Ebitda	467	134	-858	913	-2,738	540	478	187	-1,452	133	1,139	-161
Operating Income	77	24	58	64	102	45	95	91	90	62	111	95
Net Income	318	64	-716	653	-2,166	384	350	106	-1,162	69	828	-163
EPS	11.67	2.29	-25.57	23.37	-76.26	13.46	12.15	3.65	-39.59	2.33	27.89	-5.48
Key Financials TTM
Total Revenue TTM	2,554	2,541	2,567	2,580	2,563	2,605	2,671	2,720	2,769	2,779	2,802	2,805
Ebitda TTM	656	-2,549	-2,142	-806	-1,532	-247	-655	6	-342	-65	-4,529	-7,657
Operating Income TTM	224	248	269	306	332	320	338	354	357	391	475	482
Net Income TTM	319	-2,164	-1,844	-779	-1,326	-322	-637	-159	-428	-191	-3,628	-6,021
Growth Rates Quarterly
Total Revenue Growth	2.1%	-4.2%	-2.0%	2.8%	-6.3%	-9.8%	-6.7%	-7.1%	-1.4%	-3.3%	-0.3%	-8.9%
EBITDA Growth	117.1%	-75.3%	-279.4%	388.6%	-88.5%	307.1%	-58.0%	215.8%	-23.6%	103.1%	157.2%	-103.2%
Operating Income Growth	-24.0%	-46.9%	-38.8%	-29.1%	13.3%	-28.0%	-14.2%	-3.9%	-27.1%	-57.7%	-5.7%	-39.6%
Net Income Growth	114.7%	-83.3%	-304.7%	514.7%	-86.3%	456.7%	-57.8%	165.3%	-25.6%	102.0%	152.9%	-104.1%
Margins Quarterly
EBITDA Margin	71.7%	22.8%	-128.5%	140.5%	-428.8%	88.5%	70.2%	29.6%	-213.2%	19.6%	155.9%	-23.7%
Operating Income Margin	11.8%	4.0%	8.7%	9.9%	15.9%	7.3%	14.0%	14.4%	13.2%	9.1%	15.2%	13.9%
Net Income Margin	48.8%	10.9%	-107.2%	100.5%	-339.2%	62.9%	51.3%	16.8%	-170.6%	10.2%	113.4%	-23.9%
Cash & Debt
Total Cash	1,374	1,660	1,664	1,622	1,616	1,646	1,607	1,759	1,723	1,851	1,791	1,850
Total Debt	1,406	1,370	1,375	1,388	1,393	1,400	1,406	1,405	1,382	1,382	1,388	1,379
Net Debt / (Cash)	33	-291	-290	-234	-223	-246	-202	-354	-340	-470	-403	-471
Cash Flows Quarterly
FCF from Operations	116	130	124	164	98	70	81	98	98	98	80	11
Cash Flows TTM
FCF from Operations TTM	534	515	455	412	346	347	375	374	287	242	194	286
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	140	102	0	98	101	5	200	21	207	-0	91	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	724.0%	-	-	-	-	-	-	-	-	-	-	-
Return on Invested Capital (ROIC) TTM
ROIC TTM	484.9%	-	-	-	-	-	-	-	-	-	-	-

Segment Financials

Revenue by Segment

$ Mil	2024	2023	2022	2021	2020
Clinical Diagnostics	1,489	1,451	1,516	1,305	1,412
Life Science	1,178	1,347	1,401	1,232	886
Other Operations	4	4	6	9	14
Total	2,671	2,802	2,922	2,546	2,312

Operating Income by Segment

$ Mil	2024	2023	2022	2020
Clinical Diagnostics	764	754	182	148
Life Science	664	814	320	72
Other Operations	-1	-2	-1	-2
Research and development expense	-247	-257
Selling, general and administrative expense	-842	-828
Foreign currency exchange gains (losses), net				-2
Net corporate operating, interest and other expense, net not allocated to segments				-13
Other income (expense), net				26
Total	338	483	500	230

Assets by Segment

$ Mil	2024	2023	2022	2021	2020
Other long-term assets	8,114			9,847	4,863
Cash, short-term investments and other current assets	2,268			1,098	1,234
Property, plant and equipment, net, and operating lease right-of-use assets	724			53	67
Clinical Diagnostics	493	449	364	1,066	1,076
Goodwill, net	414			292	264
Life Science	287	270	208	607	496
Other Operations	0	1	1	10	9
Total	12,299	719	572	12,973	8,009

	1M	2M	3M	6M	1Y	3Y
Beta	�	-0.33	-0.20	-0.20	-0.13	0.08
Up Beta	�	-0.36	-0.23	-0.53	-0.49	0.05
Down Beta	�	-0.00	0.02	0.10	0.15	-0.00
Up Capture	0%	-36%	-20%	-16%	-7%	-0%
Bmk +ve Days	10	22	35	71	142	415
Stock +ve Days	0	1	1	3	10	34
Down Capture	-0%	-48%	-32%	21%	24%	57%
Bmk -ve Days	11	19	27	54	106	334
Stock -ve Days	0	1	1	4	10	35

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
7/31/2025
5/1/2025	0.0%	0.0%	6.7%
2/13/2025	0.0%	0.0%	-14.8%
10/30/2024	0.0%	0.0%	0.3%
8/1/2024	11.1%	11.1%	11.1%
5/7/2024	0.0%	0.0%	3.0%
2/15/2024	7.4%	2.9%	1.1%
10/26/2023	-10.0%	-9.3%	-0.3%
...
SUMMARY STATS
# Positive	18	18	13
# Negative	5	5	10
Median Positive	0.0%	2.4%	3.5%
Median Negative	-6.0%	-9.2%	-6.1%
Max Positive	11.1%	13.7%	14.7%
Max Negative	-10.0%	-20.1%	-20.7%

	Forward Returns
7/31/2025
5/1/2025	0.0%	0.0%	6.7%
2/13/2025	0.0%	0.0%	-14.8%
10/30/2024	0.0%	0.0%	0.3%
8/1/2024	11.1%	11.1%	11.1%
5/7/2024	0.0%	0.0%	3.0%
2/15/2024	7.4%	2.9%	1.1%
10/26/2023	-10.0%	-9.3%	-0.3%
8/3/2023	0.0%	0.0%	0.0%
5/4/2023	0.0%	-20.1%	-20.7%
2/16/2023	0.0%	0.0%	14.7%
10/27/2022	-9.1%	-9.1%	3.5%
7/28/2022	0.0%	13.7%	7.1%
2/10/2022	4.9%	1.8%	-10.8%
10/28/2021	0.0%	7.5%	2.8%
7/29/2021	0.0%	9.3%	9.3%
4/29/2021	0.0%	0.0%	-5.6%
2/11/2021	4.7%	4.7%	-5.4%
10/29/2020	2.7%	4.3%	-6.1%
7/30/2020	-2.8%	-2.4%	-3.4%
5/6/2020	4.6%	6.4%	4.4%
2/13/2020	6.3%	6.4%	-12.1%
10/31/2019	-0.1%	0.6%	0.6%
SUMMARY STATS
# Positive	18	18	13
# Negative	5	5	10
Median Positive	0.0%	2.4%	3.5%
Median Negative	-6.0%	-9.2%	-6.1%
Max Positive	11.1%	13.7%	14.7%
Max Negative	-10.0%	-20.1%	-20.7%

SEC Filings

Expand for More

Report Date	Filing
6302025	10-Q 6/30/2025
3312025	10-Q 3/31/2025
12312024	10-K 12/31/2024
9302024	10-Q 9/30/2024
6302024	10-Q 6/30/2024
3312024	10-Q 3/31/2024
12312023	10-K 12/31/2023
9302023	10-Q 9/30/2023
6302023	10-Q 6/30/2023
3312023	10-Q 3/31/2023
12312022	10-K 12/31/2022
9302022	10-Q 9/30/2022
6302022	10-Q 6/30/2022
3312022	10-Q 3/31/2022
12312021	10-K 12/31/2021
9302021	10-Q 9/30/2021

Insider Activity

Expand for More

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Bio-Rad Laboratories (BIO-B)

Market Price (9/4/2025): $286.9 | Market Cap: $7.8 BilSector: Health Care | Industry: Life Sciences Tools & Services

Bio-Rad Laboratories (BIO-B)

Market Price (9/4/2025): $286.9Market Cap: $7.8 BilSector: Health CareIndustry: Life Sciences Tools & Services

Investment Highlights

Market Valuation

Stock Price Chart

Market Cap Chart

Business Description

Price Returns Compared

Interactive Breakdown

Better Bets than Bio-Rad Laboratories (BIO-B)

Latest Trefis Analyses

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Bio-Rad Laboratories

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (9/4/2025): $286.9 | Market Cap: $7.8 Bil
Sector: Health Care | Industry: Life Sciences Tools & Services

Market Price (9/4/2025): $286.9
Market Cap: $7.8 Bil
Sector: Health Care
Industry: Life Sciences Tools & Services